BRPI0922820A2 - métodos e usos envolvendo a proteína de ligação ao heme 1 - Google Patents

métodos e usos envolvendo a proteína de ligação ao heme 1

Info

Publication number
BRPI0922820A2
BRPI0922820A2 BRPI0922820A BRPI0922820A BRPI0922820A2 BR PI0922820 A2 BRPI0922820 A2 BR PI0922820A2 BR PI0922820 A BRPI0922820 A BR PI0922820A BR PI0922820 A BRPI0922820 A BR PI0922820A BR PI0922820 A2 BRPI0922820 A2 BR PI0922820A2
Authority
BR
Brazil
Prior art keywords
heme
methods
binding protein
uses involving
involving
Prior art date
Application number
BRPI0922820A
Other languages
English (en)
Inventor
Alexandra Ferrier
Alexandra Krug
Christian Viskov
Hartmut Strobel
Jochen Kruip
Johann Gassenhuber
Kathrin Heermeier
Natalie Karst
Paulus Wohlfart
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of BRPI0922820A2 publication Critical patent/BRPI0922820A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
BRPI0922820A 2008-12-04 2009-11-27 métodos e usos envolvendo a proteína de ligação ao heme 1 BRPI0922820A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08291148 2008-12-04
PCT/EP2009/065989 WO2010063652A1 (en) 2008-12-04 2009-11-27 Methods and uses involving heme binding protein 1

Publications (1)

Publication Number Publication Date
BRPI0922820A2 true BRPI0922820A2 (pt) 2015-12-22

Family

ID=40873319

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0922820A BRPI0922820A2 (pt) 2008-12-04 2009-11-27 métodos e usos envolvendo a proteína de ligação ao heme 1

Country Status (15)

Country Link
US (1) US8652785B2 (pt)
EP (1) EP2374005A1 (pt)
JP (1) JP2012510801A (pt)
KR (1) KR20110101142A (pt)
CN (1) CN102239414A (pt)
AR (1) AR074450A1 (pt)
AU (1) AU2009324228A1 (pt)
BR (1) BRPI0922820A2 (pt)
CA (1) CA2745240A1 (pt)
IL (1) IL213286A0 (pt)
MX (1) MX2011005330A (pt)
RU (1) RU2520748C2 (pt)
SG (1) SG171949A1 (pt)
TW (1) TW201033614A (pt)
WO (1) WO2010063652A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009324228A1 (en) * 2008-12-04 2011-06-23 Sanofi-Aventis Methods and uses involving Heme binding protein 1
WO2015006650A1 (en) * 2013-07-11 2015-01-15 Yi Wang Instant view of protein bands
TWI665447B (zh) * 2016-11-16 2019-07-11 財團法人金屬工業研究發展中心 檢測微粒及其製造方法
US20200237652A1 (en) * 2017-08-08 2020-07-30 Csl Behring Ag Hemopexin formulations
EP3959311A1 (en) 2019-04-25 2022-03-02 Impossible Foods Inc. Strains and methods for production of heme-containing proteins
KR20230072367A (ko) 2021-11-17 2023-05-24 인하대학교 산학협력단 Hebp1 단백질 또는 그를 코딩하는 폴리뉴클레오티드를 유효성분으로 포함하는 발기부전, 허혈성질환 또는 말초신경질환 예방 또는 치료용 약학 조성물
CN114230652A (zh) * 2022-01-21 2022-03-25 湖北民族大学 一种红米稻血红素结合蛋白的原核细胞高效表达方法
CN115753706B (zh) * 2022-11-03 2023-05-05 兰州大学 一种血红素的荧光检测方法及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI963989A (fi) 1996-10-04 1998-04-05 Wallac Oy Homogeenisiä määritysmenetelmiä, jotka perustuvat luminesenssienergiasiirtoon
CN100357433C (zh) * 1999-04-16 2007-12-26 耶鲁大学 可用于基因治疗和治疗性筛选的eNOS突变
US20020048581A1 (en) 2000-07-18 2002-04-25 King George L. Modulation of nitric oxide synthase by PKC
WO2002082082A2 (en) * 2001-04-09 2002-10-17 Boehringer Ingelheim Pharmaceuticals, Inc. Fluorescence polarization assay
IL146389A0 (en) 2001-11-08 2002-07-25 Isp Finetech Ltd Process for the preparation of dronedarone
EP1578367A4 (en) * 2002-11-01 2012-05-02 Genentech Inc COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE DISEASES
CA2810292C (en) * 2004-05-14 2015-09-29 Euroscreen S.A. Ligand for g-protein coupled receptor fprl2 and uses thereof
US20060135610A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Cardiovascular compositions
RU2334466C2 (ru) * 2006-07-11 2008-09-27 Федеральное государственное учреждение "Научно-исследовательский институт кардиологии имени В.А. Алмазова Федерального агентства по здравоохранению и социальному развитию" Способ определения риска развития сердечно-сосудистых осложнений у больных гипертонической болезнью
JP2010515467A (ja) * 2007-01-15 2010-05-13 セントレ・ドゥ・レシェルシェ・パブリック・ドゥ・ラ・サン 心筋梗塞及び心不全における診断マーカー及び薬剤設計のためのプラットホーム
GB0719180D0 (en) 2007-10-02 2007-11-14 Cambrex Karlskoga Ab New process
AU2009324228A1 (en) * 2008-12-04 2011-06-23 Sanofi-Aventis Methods and uses involving Heme binding protein 1

Also Published As

Publication number Publication date
RU2520748C2 (ru) 2014-06-27
KR20110101142A (ko) 2011-09-15
RU2011127117A (ru) 2013-01-10
SG171949A1 (en) 2011-07-28
TW201033614A (en) 2010-09-16
EP2374005A1 (en) 2011-10-12
US8652785B2 (en) 2014-02-18
IL213286A0 (en) 2011-07-31
CN102239414A (zh) 2011-11-09
US20110306553A1 (en) 2011-12-15
MX2011005330A (es) 2011-06-16
AR074450A1 (es) 2011-01-19
JP2012510801A (ja) 2012-05-17
AU2009324228A1 (en) 2011-06-23
WO2010063652A1 (en) 2010-06-10
CA2745240A1 (en) 2010-06-10

Similar Documents

Publication Publication Date Title
BRPI0922820A2 (pt) métodos e usos envolvendo a proteína de ligação ao heme 1
DK2147315T3 (da) Diabetesrelaterede biomarkører og fremgangsmåder til anvendelse deraf
DK2032702T3 (da) Modificeret dicamba-monooxygenase-enzym og fremgangsmåder til dets anvendelse
DK2240595T4 (da) Glykosyleret proteinekspression i prokaryoter
DK1867743T5 (da) Austenitisk rustfrit stål
EP1986927A4 (en) IMPROVED LABELING PROCESSOR AND RELATED METHOD
DK2094292T3 (da) Salpeteroxid-blokeret tværbundet tetramerisk hæmoglobin
SE0702055L (sv) Andedräktsanalysator
BRPI0820387A2 (pt) Agentes de ligação de wise e epítopos
EP2217371A4 (en) CATALYSTS AND RELATED METHODS
EP2262840A4 (en) METALLOPROTEINASE 9 AND METALLOPROTEINASE 2 BINDING PROTEINS
DK2252633T3 (da) Anti-TrkA antistoffer og derivater deraf
EP1991565A4 (en) SHIGA TOXOID CHIMERIC PROTEINS
EP2158328A4 (en) FAST PROTEIN MARKING AND ANALYSIS
DE602007007718D1 (de) Spielzeugroboter und Montageverfahren dafür
BRPI0621937A2 (pt) suplemento alimentar baseado em licopeno biológico e processo de co-extração de licopeno biológico
BRPI0719904A2 (pt) Aço inoxidável martensítico
GB0602992D0 (en) Methods, genes and proteins
BRPI0911411A2 (pt) montagem e método de carrossel modular
DE602006018129D1 (de) Codierer, decodierer und verfahren dafür
NO20082399L (no) Rorforgreningsanordning
EP1999558A4 (en) METHOD FOR IDENTIFYING FATS AND LOW ANIMALS BY CLASSIFICATION
ZA201100019B (en) Variant hhip1 protein and methods and uses thereof
EP1941435A4 (en) FRAMEWORK FOR WRITING AND EXECUTING DIALOGUES
GB0725153D0 (en) Protein analysis

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2372 DE 21-06-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.